Works matching IS 18696953 AND DT 2022 AND VI 13 AND IP 3

Results: 12

Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION Study.

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 569, doi. 10.1007/s13300-022-01225-z

By:

Malik, Rayaz A.;
Elhadd, Tarik;
Alattar, Abdulnabi;
Al Shaikh, Abdulrahman;
Al Randi, Muneera;
Arora, Ravi;
Al-Sifri, Saud;
Akil, Yasser;
Magdy, Amr;
Naqvi, Mubarak;
Hassanein, Mohamed

Publication type:

Article

Cystic Fibrosis-Related Diabetes Mellitus and Pregnancy: A Retrospective Study.

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 481, doi. 10.1007/s13300-022-01223-1

By:

Davern, Recie;
Balan, Gabriela;
Kilcoyne, Ciara;
Coveney, Ciara;
Devine, Hilary;
Walsh, Jennifer M.;
Higgins, Mary;
Hatunic, Mensud

Publication type:

Article

The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark.

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 489, doi. 10.1007/s13300-022-01221-3

By:

Ehlers, Lars H.;
Lamotte, Mark;
Ramos, Mafalda C.;
Sandgaard, Susanne;
Holmgaard, Pia;
Kristensen, Malene M.;
Ejskjaer, Niels

Publication type:

Article

Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 551, doi. 10.1007/s13300-022-01218-y

By:

Di Loreto, Chiara;
Minarelli, Viviana;
Nasini, Giovanni;
Norgiolini, Roberto;
Del Sindaco, Paola

Publication type:

Article

Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study.

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 453, doi. 10.1007/s13300-022-01217-z

By:

Nikolic, Dragana;
Patti, Angelo M.;
Giglio, Rosaria V.;
Chianetta, Roberta;
Castellino, Giuseppa;
Magán-Fernández, Antonio;
Citarrella, Roberto;
Papanas, Nikolaos;
Janez, Andrej;
Stoian, Anca Pantea;
Rizvi, Ali A.;
Rizzo, Manfredi

Publication type:

Article

Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition.

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 535, doi. 10.1007/s13300-022-01216-0

By:

Munshi, Medha N.;
Sy, Sarah L.;
Florez, Hermes J.;
Huang, Elbert S.;
Lipska, Kasia J.;
Myrka, Anne;
Marcos Valencia, Willy;
Yu, Joyce;
Triller, Darren M.

Publication type:

Article

Mortality Rate Associated with Diabetes: Outcomes From a General Practice Level Analysis in England Using the Royal College of General Practitioners (RCGP) Database Indicate Stability Over a 15 Year Period.

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 505, doi. 10.1007/s13300-022-01215-1

By:

Heald, Adrian;
Stedman, Mike;
Robinson, Adam;
Davies, Mark;
Livingston, Mark;
Alshames, Ramadan;
Moreno, Gabriela;
Gadsby, Roger;
Rayman, Gerry;
Gibson, Martin;
de Lusignan, Simon;
Whyte, Martin

Publication type:

Article

Effect of Digital Lifestyle Management on Metabolic Control and Quality of Life in Patients with Well-Controlled Type 2 Diabetes.

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 423, doi. 10.1007/s13300-022-01214-2

By:

Dwibedi, Chinmay;
Abrahamsson, Birgitta;
Rosengren, Anders H.

Publication type:

Article

Conversations and Reactions Around Severe Hypoglycemia (CRASH): Japan Results From a Global Survey of People with T1DM or Insulin-Treated T2DM and Caregivers.

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 517, doi. 10.1007/s13300-022-01211-5

By:

Iwahori, Toshiyuki;
Snoek, Frank;
Nagai, Yukiko;
Spaepen, Erik;
Mitchell, Beth D.;
Peyrot, Mark

Publication type:

Article

Treatment Patterns and Outcomes Before and After Humulin R U-500 Initiation Among US Patients with Type 2 Diabetes Previously Prescribed ≤ 200 Units/day of U-100 Insulin.

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 465, doi. 10.1007/s13300-022-01209-z

By:

Chen, Jieling;
Borra, Sujana;
Huang, Ahong;
Fan, Ludi;
Pollom, Roy Daniel;
Hood, Robert C.

Publication type:

Article

Clinical Characteristics of Peripheral Neuropathy in Kenyan Patients with HIV Infection Compared with Patients with Concurrent HIV Infection and Diabetes Mellitus.

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 441, doi. 10.1007/s13300-022-01205-3

By:

Kuka, Werimo Pascal;
Shah, Jasmit;
Alam, Uazman;
Shah, Reena;
Sokhi, Dilraj Singh

Publication type:

Article

Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations.

Published in:

Diabetes Therapy, 2022, v. 13, n. 3, p. 389, doi. 10.1007/s13300-021-01198-5

By:

Górriz, José L.;
Romera, Irene;
Cobo, Amelia;
O'Brien, Phillipe D.;
Merino-Torres, Juan F.

Publication type:

Article